Connection

Evangelos Terpos to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Evangelos Terpos has written about Dose-Response Relationship, Drug.
Evangelos Terpos
Connection Strength
0.018
Dose-Response Relationship, Drug
  1. Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies. Am J Hematol. 2015 Apr; 90(4):E60-5.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.